Access cutting-edge lung cancer treatment through this clinical trial at a research site in Fountain Valley. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Fountain Valley at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
This clinical trial is designed to assess the efficacy and safety of trastuzumab deruxtecan (T-DXd; Enhertu®) in combination with pembrolizumab versus platinum-based chemotherapy in combination with pembrolizumab in participants with no prior therapy for locally advanced unresectable or metastatic non-squamous NSCLC, whose tumors have HER2-overexpressing and PD-L1 TPS \<50% without known AGA that have locally available therapies targeting their AGAs in first-line advanced/metastatic setting.
Sponsor: Daiichi Sankyo
Check if you qualify for this lung cancer clinical trial in Fountain Valley, CA
If you're searching for lung cancer treatment options in Fountain Valley, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fountain Valley research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.